Pharma Journalist 7836 posts 0 comments

Abzena has entered into a manufacturing agreement with University College London (UCL). Under the agreement, Abzena will manufacture Magacizumab, an antibody created using the…
Read More...

Xbrane Biopharma has been granted GMP (Good Manufacturing Practice) certification for its Spherotide production facility by AIFA, the Italian Medicines Agency. The GMP certification…
Read More...

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a…
Read More...

CanniMed Therapeutics Inc. and CTT Pharmaceutical Holdings Inc.have entered into a definitive contractual relationship for the licensing of CTT’s Orally Dissolvable Thin Film (ODF)…
Read More...

Immune Pharmaceuticals Inc., will announce on Monday, February 20th, 2017 at the Acute Leukemia XVI symposium in Munich, Germany that it will be launching REMAIN™, an international…
Read More...

The US Food and Drug Administration has accepted for filing of Intellipharmaceutics International’s New Drug Application ("NDA") seeking authorization to market its Rexista…
Read More...

Momenta Pharmaceuticals has announced that Pfizer, Sandoz’s contracted Glatopa (glatiramer acetate injection) fill/finish manufacturing partner has received a warning letter from the…
Read More...

Global healthcare and life science company Arix Bioscience has raised £100m in its Initial Public Offering (IPO) on the main market of the London Stock Exchange. The Offer was…
Read More...

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI (brexpiprazole) for the treatment of schizophrenia in adults.…
Read More...

Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics announced the initiation of a Phase 1 clinical study to…
Read More...